1047 related articles for article (PubMed ID: 29073341)
21. Global metabolic profiling using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Qi Y; Song Y; Gu H; Fan G; Chai Y
Methods Mol Biol; 2014; 1198():15-27. PubMed ID: 25270920
[TBL] [Abstract][Full Text] [Related]
22. Metabolomics, pathway regulation, and pathway discovery.
Zhang GF; Sadhukhan S; Tochtrop GP; Brunengraber H
J Biol Chem; 2011 Jul; 286(27):23631-5. PubMed ID: 21566142
[TBL] [Abstract][Full Text] [Related]
23. Metabolomics as a Tool to Understand Pathophysiological Processes.
Ivanisevic J; Thomas A
Methods Mol Biol; 2018; 1730():3-28. PubMed ID: 29363062
[TBL] [Abstract][Full Text] [Related]
24. Challenges in mass spectrometry based targeted metabolomics.
Koal T; Deigner HP
Curr Mol Med; 2010 Mar; 10(2):216-26. PubMed ID: 20196726
[TBL] [Abstract][Full Text] [Related]
25. Overlap in serum metabolic profiles between non-related diseases: Implications for LC-MS metabolomics biomarker discovery.
Lindahl A; Forshed J; Nordström A
Biochem Biophys Res Commun; 2016 Sep; 478(3):1472-7. PubMed ID: 27581198
[TBL] [Abstract][Full Text] [Related]
26. Human metabolomics: strategies to understand biology.
Ramautar R; Berger R; van der Greef J; Hankemeier T
Curr Opin Chem Biol; 2013 Oct; 17(5):841-6. PubMed ID: 23849548
[TBL] [Abstract][Full Text] [Related]
27. New findings on urinary prostate cancer metabolome through combined GC-MS and
Lima AR; Pinto J; Barros-Silva D; Jerónimo C; Henrique R; Bastos ML; Carvalho M; Guedes Pinho P
Metabolomics; 2020 Jun; 16(6):70. PubMed ID: 32495062
[TBL] [Abstract][Full Text] [Related]
28. Tissue Multiplatform-Based Metabolomics/Metabonomics for Enhanced Metabolome Coverage.
Vorkas PA; Abellona U MR; Li JV
Methods Mol Biol; 2018; 1738():239-260. PubMed ID: 29654595
[TBL] [Abstract][Full Text] [Related]
29. Precision of a Clinical Metabolomics Profiling Platform for Use in the Identification of Inborn Errors of Metabolism.
Ford L; Kennedy AD; Goodman KD; Pappan KL; Evans AM; Miller LAD; Wulff JE; Wiggs BR; Lennon JJ; Elsea S; Toal DR
J Appl Lab Med; 2020 Mar; 5(2):342-356. PubMed ID: 32445384
[TBL] [Abstract][Full Text] [Related]
30. Optimization of metabolite extraction of human vein tissue for ultra performance liquid chromatography-mass spectrometry and nuclear magnetic resonance-based untargeted metabolic profiling.
Anwar MA; Vorkas PA; Li JV; Shalhoub J; Want EJ; Davies AH; Holmes E
Analyst; 2015 Nov; 140(22):7586-97. PubMed ID: 26468486
[TBL] [Abstract][Full Text] [Related]
31. High-throughput ultra-performance liquid chromatography-mass spectrometry characterization of metabolites guided by a bioinformatics program.
Zhang AH; Wang P; Sun H; Yan GL; Han Y; Wang XJ
Mol Biosyst; 2013 Sep; 9(9):2259-65. PubMed ID: 23821129
[TBL] [Abstract][Full Text] [Related]
32. Urinary metabolic phenotyping of mucopolysaccharidosis type I combining untargeted and targeted strategies with data modeling.
Tebani A; Schmitz-Afonso I; Abily-Donval L; Héron B; Piraud M; Ausseil J; Brassier A; De Lonlay P; Zerimech F; Vaz FM; Gonzalez BJ; Marret S; Afonso C; Bekri S
Clin Chim Acta; 2017 Dec; 475():7-14. PubMed ID: 28982054
[TBL] [Abstract][Full Text] [Related]
33. Advanced Mass Spectrometry-Based Biomarker Identification for Metabolomics of Diabetes Mellitus and Its Complications.
Zhang F; Shan S; Fu C; Guo S; Liu C; Wang S
Molecules; 2024 May; 29(11):. PubMed ID: 38893405
[TBL] [Abstract][Full Text] [Related]
34. Biomarker discovery in biological specimens (plasma, hair, liver and kidney) of diabetic mice based upon metabolite profiling using ultra-performance liquid chromatography with electrospray ionization time-of-flight mass spectrometry.
Tsutsui H; Maeda T; Min JZ; Inagaki S; Higashi T; Kagawa Y; Toyo'oka T
Clin Chim Acta; 2011 May; 412(11-12):861-72. PubMed ID: 21185819
[TBL] [Abstract][Full Text] [Related]
35. STRATEGIES AND CHALLENGES IN METHOD DEVELOPMENT AND VALIDATION FOR THE ABSOLUTE QUANTIFICATION OF ENDOGENOUS BIOMARKER METABOLITES USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY.
Khamis MM; Adamko DJ; El-Aneed A
Mass Spectrom Rev; 2021 Jan; 40(1):31-52. PubMed ID: 31617245
[TBL] [Abstract][Full Text] [Related]
36. Discovery and comparison of serum biomarkers for diabetes mellitus and metabolic syndrome based on UPLC-Q-TOF/MS.
Liu X; Gao X; Zhang R; Liu Z; Shen N; Di Y; Fang T; Li H; Tian F
Clin Biochem; 2020 Aug; 82():40-50. PubMed ID: 32194037
[TBL] [Abstract][Full Text] [Related]
37. Metabolomics and diabetes: analytical and computational approaches.
Sas KM; Karnovsky A; Michailidis G; Pennathur S
Diabetes; 2015 Mar; 64(3):718-32. PubMed ID: 25713200
[TBL] [Abstract][Full Text] [Related]
38. NMR-based pharmacometabonomics: A new paradigm for personalised or precision medicine.
Everett JR
Prog Nucl Magn Reson Spectrosc; 2017 Nov; 102-103():1-14. PubMed ID: 29157489
[TBL] [Abstract][Full Text] [Related]
39. Metabolomics: a revolution for novel cancer marker identification.
Bu Q; Huang Y; Yan G; Cen X; Zhao YL
Comb Chem High Throughput Screen; 2012 Mar; 15(3):266-75. PubMed ID: 22221059
[TBL] [Abstract][Full Text] [Related]
40. Personalized Metabolic Profile by Synergic Use of NMR and HRMS.
Petrella G; Montesano C; Lentini S; Ciufolini G; Vanni D; Speziale R; Salonia A; Montorsi F; Summa V; Vago R; Orsatti L; Monteagudo E; Cicero DO
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
